Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2021

Nov 15, 2021

SELL
$372.64 - $458.3 $35.8 Million - $44 Million
-96,000 Reduced 96.0%
4,000 $1.65 Million
Q3 2020

Nov 16, 2020

BUY
$175.56 - $226.45 $8.78 Million - $11.3 Million
50,000 Added 100.0%
100,000 $22.6 Million
Q1 2020

May 15, 2020

BUY
$98.9 - $178.34 $4.95 Million - $8.92 Million
50,000 New
50,000 $6.31 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $10.1B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Precept Management LLC Portfolio

Follow Precept Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Precept Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Precept Management LLC with notifications on news.